[Skip to Navigation]
May 2016

Transgender Patients, Isotretinoin, and US Food and Drug Administration–Mandated Risk Evaluation and Mitigation Strategies: A Prescription for Inclusion

Author Affiliations
  • 1Department of Dermatology, Kaiser Permanente, Pleasanton, California
JAMA Dermatol. 2016;152(5):513-514. doi:10.1001/jamadermatol.2015.5547

Caitlyn Jenner has vaulted to celebrity status, Facebook has expanded its gender nomenclature, and the Pentagon has announced plans to permit transgender service members to serve openly. Although recent news about transgender persons is not uniformly rosy—transgender persons in the United States and elsewhere are still targets of violent, sometimes lethal attacks, and voters in Houston, Texas, recently repealed that city’s Equal Rights Ordinance—transgender visibility and equality have made remarkable advances. Those advances have paralleled strides made in scientific understanding of gender, including replacement of the term gender identity disorder with gender dysphoria in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition in 2013.

Add or change institution